Physician profile
Joseph Ortenberg
NPI 1396799177
$977.78
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $304 · 2021: $102 · 2022: $33.28 · 2023: $132 · 2024: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.34 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $256.11 | 2019-2020 | |
| Teleflex LLC | $237.21 | 2024 | Deflux |
| Astellas Pharma US INC | $99.99 | 2023 | |
| Boston Scientific Corporation | $96.93 | 2019 | |
| Rochester Medical Corporation | $70.58 | 2019-2020 | |
| Palette Life Sciences, INC. | $68.65 | 2020-2022 | |
| Coloplast Corp | $61.30 | 2021-2023 | Speedicath |
| Medtronic, INC. | $47.36 | 2021 | |
| Alnylam Pharmaceuticals INC. | $25.72 | 2021 | |
| Hollister Incorporated | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ortenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.